Encompass Compliance Corp. engages in the provision of workplace drug and alcohol testing compliance services. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2000-03-13. The firm offers an annual subscription service, which maintains compliance and updates employers on the impact of the law, to their workplace. Its services include statutes, regulations, court decisions and the Drug Testing Compliance Matrix, which provides the guidance for managing the rules that apply. The company focuses on Medical Marijuana, Opiates, Synthetics, as well as other drugs and alcohol usage in the workplace. The firm also offers training modules, consulting on the implementation of this service, and training tools, as well as Claims defense services to its customers. Its solutions provide organizations with up-to-date policies, a resource center and real-time monitoring for drug and alcohol testing orders. The firm offers Risk Shield, which allows employers to create a core drug and alcohol policy and accounts for all regulations.
ENCC stock price ended at $0.01 on 月曜日, after rising 0.00%
On the latest trading day Feb 09, 2026, the stock price of ENCC rose by 0.00%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 100.00%, with prices oscillating between a daily low of $0.01 and a high of $0.02. Notably, trading volume dropped by 381.4K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 777.8K shares were traded, equating to a market value of approximately $1.4M.